Cosmos Pharmaceuticals, Inc. — Form D

Cosmos Pharmaceuticals, Inc. of MIDDLETOWN, DE, a company, filed a Form D exempt-offering notice with the SEC on 2022-06-03. The offering totals $300K, of which $175K was reported sold. Industry: Other Health Care.

Offering

Filed: 2022-06-03
Form: D
Accession: 0001567619-22-012225
Industry: Other Health Care
Exemptions: 06b
Total offering: $300K
Amount sold: $175K
Remaining: $125K
Minimum investment: $10K
Investors: 7
Date of first sale: 2022-05-31
Security types: debt
Revenue range: Decline to Disclose
SEC file number: 021-448071

Issuer

Name: Cosmos Pharmaceuticals, Inc.
CIK: 0001845816
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2017
Address: 537 WHEELMEN STREET, MIDDLETOWN, DE, 19709
Phone: 302-563-0047

Officers, directors & promoters (7)

Name	Role	Location
Joseph W White	Director	Middletown, DE
Joseph W White	Executive Officer	Middletown, DE
Alexander M Colton	Director	Middletown, DE
Alexander M Colton	Executive Officer	Middletown, DE
Philip W McBride	Executive Officer	Middletown, DE
Bart W Edmunds	Director	Middletown, DE
Christian W Colton	Director	Middletown, DE

Other filings by this issuer (2)

Filed	Form	Offering	Sold
2025-10-07	D	$1.3M	$750K
2021-02-23	D	$250K	$225K

More